• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估从母体血浆中提取甲基化游离胎儿 DNA 的方法。

Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma.

机构信息

Laboratory of Medical Genetics, Medical Research Institute, Cheil General Hospital and Women's Healthcare Center, Seoul, South Korea.

Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, 1-19, Mookjung-dong, Chung-gu, Seoul, 100-380, South Korea.

出版信息

J Assist Reprod Genet. 2018 Apr;35(4):637-641. doi: 10.1007/s10815-018-1114-8. Epub 2018 Feb 8.

DOI:10.1007/s10815-018-1114-8
PMID:29423788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5949107/
Abstract

PURPOSE

Recently, fetal placenta-specific epigenetic regions (FSERs) have been identified for quantification of cell-free fetal DNA (cff-DNA) for non-invasive prenatal testing (NIPT). The aim of this study was to evaluate the efficiencies of a column-based kit and magnetic bead-based kit for quantification of methylated FSERs from maternal plasma.

METHODS

Maternal plasma was extracted from normal pregnant women within the gestational age of 10~13 weeks (n = 24). Total cell-free DNA (cf-DNA) was extracted using a column-based kit and magnetic bead-based kit from the plasma of the same pregnant woman, respectively. Methylated FSERs were enriched from the extracted total cf-DNA using a methyl-CpG-binding domain-based protein method. The four FSERs were simultaneously quantified by multiplex real-time polymerase chain reaction.

RESULTS

Methylated FSERs were detected in all samples extracted from both kits. However, the amplification of FSERs showed significant differences in the extraction efficiency of methylated FSERs between the two extraction methods. The Ct values of methylated FSERs extracted using the column-based kit were significantly lower than those obtained using the magnetic bead-based kit (P < 0.001 for all FSERs). The quantity of methylated FSERs was significantly higher for extracted DNA using the column-based kit than that extracted using the magnetic bead-based kit (P < 0.001 for all FSERs). Time and cost for the process of extraction were similar for the column kit and magnetic bead-based kit.

CONCLUSIONS

Our findings demonstrate that the column-based kit was more effective than the magnetic bead-based kit for isolation of methylated FSERs from maternal plasma as assessed by FSER detection.

摘要

目的

最近,已经鉴定出胎儿胎盘特异性表观遗传区域(FSERs),用于定量分析游离胎儿 DNA(cff-DNA)进行非侵入性产前检测(NIPT)。本研究旨在评估基于柱和磁珠的试剂盒用于定量分析母体血浆中甲基化 FSER 的效率。

方法

从 10~13 周妊娠的正常孕妇中提取母体血浆(n=24)。分别使用基于柱和磁珠的试剂盒从同一孕妇的血浆中提取总游离 DNA(cf-DNA)。使用基于甲基化 CpG 结合域蛋白的方法从提取的总 cf-DNA 中富集甲基化 FSERs。通过多重实时聚合酶链反应同时定量四种 FSERs。

结果

从两种试剂盒提取的所有样本中均检测到甲基化 FSERs。然而,FSERs 的扩增显示出两种提取方法在提取甲基化 FSERs 的效率方面存在显著差异。使用基于柱的试剂盒提取的甲基化 FSER 的 Ct 值明显低于使用磁珠试剂盒提取的(所有 FSERs 的 P 值均<0.001)。使用基于柱的试剂盒提取的甲基化 FSER 的数量明显高于使用磁珠试剂盒提取的(所有 FSERs 的 P 值均<0.001)。两种试剂盒的提取过程的时间和成本相似。

结论

我们的研究结果表明,基于柱的试剂盒在 FSER 检测方面比磁珠试剂盒更有效地从母体血浆中分离甲基化 FSERs。

相似文献

1
Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma.评估从母体血浆中提取甲基化游离胎儿 DNA 的方法。
J Assist Reprod Genet. 2018 Apr;35(4):637-641. doi: 10.1007/s10815-018-1114-8. Epub 2018 Feb 8.
2
Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma.从母体血浆中提取甲基化游离胎儿 DNA 方法的评估和统计优化。
J Assist Reprod Genet. 2019 May;36(5):1029-1038. doi: 10.1007/s10815-019-01425-w. Epub 2019 Feb 28.
3
Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.Mrassf1a-pap,一种基于甲基化的新型检测方法,用于检测母体血浆中的游离胎儿DNA。
PLoS One. 2013 Dec 31;8(12):e84051. doi: 10.1371/journal.pone.0084051. eCollection 2013.
4
Fetal RHD detection from circulating cell-free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA.从母体血浆中循环游离胎儿DNA检测胎儿RHD:使用自动提取和冷冻DNA的诊断试剂盒的验证
Transfus Med. 2019 Dec;29(6):408-414. doi: 10.1111/tme.12605. Epub 2019 Jun 17.
5
Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.对21号染色体上胎盘DNA甲基化标记物的系统搜索:迈向基于母体血浆的胎儿21三体表观遗传学检测
Clin Chem. 2008 Mar;54(3):500-11. doi: 10.1373/clinchem.2007.098731. Epub 2008 Jan 17.
6
Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.比较 QIAamp DSP 病毒试剂盒和 QIAamp 循环核酸试剂盒从孕妇外周血中分离游离胎儿 DNA 的效果。
Mol Cell Probes. 2019 Feb;43:13-19. doi: 10.1016/j.mcp.2018.12.006. Epub 2018 Dec 22.
7
Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.全基因组 DNA 甲基化分析揭示了母体血浆中用于无创性胎儿单核苷酸多态性基因分型的胎盘表观遗传标记物。
Transfusion. 2014 Oct;54(10):2523-33. doi: 10.1111/trf.12659. Epub 2014 Apr 18.
8
Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.系统识别胎盘表观遗传特征,用于爱德华氏综合征的无创性产前检测。
PLoS One. 2010 Nov 30;5(11):e15069. doi: 10.1371/journal.pone.0015069.
9
Effective Fetal Epigenetic Biomarkers for Noninvasive Fetal Trisomy 21 Detections.用于非侵入性胎儿 21 三体检测的有效胎儿表观遗传学生物标志物。
Fetal Diagn Ther. 2019;46(2):133-138. doi: 10.1159/000494054. Epub 2018 Nov 8.
10
Diagnostic Value of Non-Invasive Prenatal Screening of β-thalassemia by Cell Free Fetal DNA and Fetal NRBC.应用游离胎儿 DNA 和有核红细胞无创产前筛查β-地中海贫血的诊断价值
Curr Mol Med. 2019;19(2):105-111. doi: 10.2174/1566524019666190226124135.

引用本文的文献

1
Design, Development, and Clinical Validation of a Novel Kit for Cell-Free DNA Extraction.一种新型无细胞DNA提取试剂盒的设计、开发及临床验证
Diagnostics (Basel). 2025 Jul 29;15(15):1897. doi: 10.3390/diagnostics15151897.
2
Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.利用循环无细胞 DNA 进行生物标志物发现的进展,用于早期检测肝细胞癌。
WIREs Mech Dis. 2023 May-Jun;15(3):e1598. doi: 10.1002/wsbm.1598. Epub 2023 Jan 25.
3
Appraisal on the Wound Healing Potential of DC. and Hochst Essential Oil Nanoemulsion Topical Preparation.DC.与赫斯特精油纳米乳剂局部制剂的伤口愈合潜力评估
Front Pharmacol. 2022 Jul 26;13:940988. doi: 10.3389/fphar.2022.940988. eCollection 2022.
4
A novel method for extracting circulating cell-free DNA from whole blood samples and its utility in the non-invasive prenatal test.一种从全血样本中提取循环无细胞 DNA 的新方法及其在无创性产前检测中的应用。
Prenat Diagn. 2022 Aug;42(9):1173-1181. doi: 10.1002/pd.6212. Epub 2022 Aug 5.
5
Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing.脂质代谢影响无创产前检测中的胎儿游离DNA比例及筛查失败情况。
Front Med (Lausanne). 2022 Jan 12;8:811385. doi: 10.3389/fmed.2021.811385. eCollection 2021.
6
Comparison of indications and results of prenatal invasive diagnostic tests before and after the implementation of the use of cell-free fetal DNA: a tertiary referral center experience.比较实施游离胎儿 DNA 检测前后产前有创诊断检测的适应证和结果:一家三级转诊中心的经验。
J Assist Reprod Genet. 2020 Aug;37(8):2019-2024. doi: 10.1007/s10815-020-01825-3. Epub 2020 May 21.
7
Potential of Next-Generation Sequencing in Noninvasive Fetal Molecular Blood Group Genotyping.下一代测序技术在无创胎儿分子血型基因分型中的应用潜力
Transfus Med Hemother. 2020 Feb;47(1):14-22. doi: 10.1159/000505161. Epub 2020 Jan 20.
8
Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.在无创产前检测(NIPT)中对短cfDNA片段进行测序,可提高孕妇体重指数较高和孕早期时的胎儿游离DNA比例。
Am J Transl Res. 2019 Jul 15;11(7):4450-4459. eCollection 2019.
9
Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma.从母体血浆中提取甲基化游离胎儿 DNA 方法的评估和统计优化。
J Assist Reprod Genet. 2019 May;36(5):1029-1038. doi: 10.1007/s10815-019-01425-w. Epub 2019 Feb 28.

本文引用的文献

1
Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.21号染色体上用于胎儿21三体非侵入性产前检测的新型表观遗传标记。
J Mol Diagn. 2016 May;18(3):378-387. doi: 10.1016/j.jmoldx.2015.12.002. Epub 2016 Mar 4.
2
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood.利用孕妇血液中游离胎儿DNA对胎儿21三体进行无创产前诊断。
Obstet Gynecol Sci. 2013 Mar;56(2):58-66. doi: 10.5468/OGS.2013.56.2.58. Epub 2013 Mar 12.
3
Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.非侵入性染色体评估(NICE)研究:一项多中心前瞻性队列研究的结果,用于检测胎儿 21 三体和 18 三体。
Am J Obstet Gynecol. 2012 Aug;207(2):137.e1-8. doi: 10.1016/j.ajog.2012.05.021. Epub 2012 Jun 1.
4
Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.在孕早期母体外周血中进行非侵入性的胎儿 21 三体综合征的表观遗传学检测。
PLoS One. 2011;6(11):e27709. doi: 10.1371/journal.pone.0027709. Epub 2011 Nov 23.
5
Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma.利用孕早期母体外周血循环胎儿 DNA 有效检测胎儿性别。
FASEB J. 2012 Jan;26(1):250-8. doi: 10.1096/fj.11-191429. Epub 2011 Sep 30.
6
Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21.胎儿特异性 DNA 甲基化比率可实现 21 三体综合征的无创性产前诊断。
Nat Med. 2011 Apr;17(4):510-3. doi: 10.1038/nm.2312. Epub 2011 Mar 6.
7
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.母体外周血游离 DNA 测序揭示胎儿全基因组遗传和突变特征。
Sci Transl Med. 2010 Dec 8;2(61):61ra91. doi: 10.1126/scitranslmed.3001720.
8
Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.非侵入性产前检测 21 三体综合征的表观遗传-遗传染色体剂量方法。
Clin Chem. 2010 Jan;56(1):90-8. doi: 10.1373/clinchem.2009.134114. Epub 2009 Oct 22.
9
The use of carrier RNA to enhance DNA extraction from microfluidic-based silica monoliths.使用载体RNA增强从基于微流体的硅胶整体柱中提取DNA。
Anal Chim Acta. 2009 Oct 12;652(1-2):231-3. doi: 10.1016/j.aca.2009.03.038. Epub 2009 Mar 31.
10
A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.基于微阵列的方法鉴定胎儿疾病无创诊断的表观遗传生物标志物。
Prenat Diagn. 2009 Nov;29(11):1020-30. doi: 10.1002/pd.2335.